Streetbeat News

Regulatory

AYRO

Electric vehicle manufacturer AYRO has submitted its new electric vehicle, Vanish, for testing.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:18 pm

F

Ford and SK Innovation's joint venture, BlueOvalSK, is set to receive a $9.2 billion government loan for battery plants in Kentucky and Tennessee, according to the Energy Department.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:17 pm

SEE

Seelos Therapeutics has closed enrollment for its registration-directed study of SLS-002, a treatment for acute suicidal ideation and behavior in adults with major depressive disorder.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:09 pm

BMRN

BioMarin Pharmaceutical (BMRN) will present data from the longest and largest hemophilia gene therapy clinical trial program, ROCTAVIAN, at the International Society on Thrombosis and Haemostasis 2023 Congress.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:05 pm

HZNP

Horizon Therapeutics reports positive topline data from Phase 3 clinical trial (OPTIC-J) in Japan for TEPEZZA (teprotumumab-trbw) in treating active thyroid eye disease (TED). At week 24, 89% of patients treated with TEPEZZA showed clinically meaningful improvement compared to 11% receiving placebo.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:05 pm

APM

Aptorum Group has submitted the Phase 1b/2a clinical trial protocol of SACT-1, an orally administered repurposed small molecule drug for the treatment of neuroblastoma, to the US FDA. The trial will study SACT-1 in combination with chemotherapy for first relapse or refractory high-risk neuroblastoma patients.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:04 pm

LIFE

The European Commission has granted Orphan Drug Designation to aTyr Pharma's Efzofitimod for the treatment of systemic sclerosis. This designation provides regulatory and financial incentives for the development of the drug.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:04 pm

JSPR

Jasper Therapeutics has announced the dosing of the first patient in a Phase 1 trial of Briquilimab for lower-risk myelodysplastic syndrome. This marks a significant milestone for the company's clinical development program.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:03 pm

CDTX

Cidara Therapeutics has received FDA Fast Track designation for its novel drug-Fc conjugate, CD388, targeting Influenza A and B. This designation will expedite the development and review process for the drug.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:01 pm

LLY

MRK

PFE

Pharmaceutical lobbying groups, including PhRMA, have filed a lawsuit against the Biden administration over Medicare's new powers to reduce drug prices for seniors. The Inflation Reduction Act, which allows Medicare to negotiate drug prices, is anticipated to impact the pharmaceutical industry's profits. Eli Lilly, Pfizer, and Merck have expressed concerns about the potential impact on drug development.

Portfolio Pulse from Vandana Singh

June 22, 2023 | 11:38 am